STOCK MARKET BSE NSE

US firm, IIT-M collaborate to bring rapid test to India

Point-of-care diagnostics, or near-patient testing, is a type of medical diagnostic test that enables accurate results within minutes.

Published: 18th September 2020 05:29 AM  |   Last Updated: 18th September 2020 05:29 AM   |  A+A-

IIT Madras

IIT Madras (File photo | EPS)

By Express News Service

CHENNAI: Ricovr Healthcare Inc., a US-based rapid diagnostics platform company, and IIT-Madras have developed a point-of-care Covid-19 antigen test that can provide results in five minutes using saliva samples, said a statement on Thursday.

Point-of-care diagnostics, or near-patient testing, is a type of medical diagnostic test that enables accurate results within minutes. This project won the prestigious ‘Ignition Grants’ Award from the US India Science and Technology Endowment Fund (USISTEF), the statement said adding that the grant was won after a binational review process to address the Covid-19 challenge. USISTEF is a joint fund established by the US and India.

IIT-M is collaborating with Ricovr to bring this antigen test to the market soon. VV Raghavendra Sai, Department of Applied Mechanics, IIT Madras, said, “This technology is different from other molecular and antibody-based tests in that it can detect the presence of active viral particles on the spot without needing a specialised apparatus.”



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

IPL_2020
flipboard facebook twitter whatsapp